Last few years Indian Pharma Companies are marred by the challenge of how to sustain growth without failing in compliance to regulatory requirements. The answer to this challenge can be found in innovating operations and the new capabilities operational teams in pharma plants need to have. What's Working Well is a program to introduce ground rules for dealing with the challenge.

1. What’s Working Well
Ground Rules for Generics Pharmaceutical Plants in sustaining growth without making compromises
Contact: lolla@cvmark.com or call +91 94480 70081
#2304 Nandi Park, Gottigere, Bannergatta Road, Bangalore-560083. INDIA
Till recently, Generics Pharmaceutical Companies have been
growing at a scorching pace; however today, they are at an inflection
point. In attempting to do justice with their historical growth, they face
enormous challenges due to growing pricing pressure, complex market
dynamics and increased scrutiny of their plant operations. Amongst other
things, the whole industry is looking out for a way to sustain growth without
making costly compromises.
For over a decade, we have been witnessing the changing face of
Pharmaceutical plants as we continue to handhold their teams in dealing
with big challenges. Our collaborative work with operations management
teams in different organizations has led to the game changing book, ‘The
Path – Leveraging Operations in a Complex and Chaotic
World’. As more and more organizations adopt the
guidelines of The Path, it is becoming clearer to us and
our clients about what’s working well and what’s really
messing up with the operations of Pharmaceutical Plants in India. We have now
distilled observations from a variety of Pharmaceutical Plants into a set of guidelines that are based on well
grounded principles and proven practices.
With the beginning of the new year 2017, we offer ‘What’s Working Well’, a new one day program
to introduce these well grounded and proven guidelines to Pharmaceutical Plants in India. This, we believe
may turn out to innovate the approach to operations for several organizations in their quest for achieving
sustained high growth without making bad compromises.
The fast paced program
takes a fresh look at
Pharmaceutical operations in
India and offers a participative
exposure on the underlying
phenomenon, principles and
behavior of high performance
operations to the senior
management teams. Plenty of
case studies, discussions on
evolving patterns of operational
rules and recognition of new
competencies for succeeding in
today’s environment, make the sessions an exciting and fruitful learning experience.
The program is led by Dr. Shridhar Lolla, a specialist in Organizational Effectiveness and Focused Management. He
handholds Pharmaceutical organizations in dramatically improving impact of manufacturing operations on business,
without incurring costly trade-offs and burn-outs. He is the author of two game changing books, 'The Path -
Leveraging Operational Excellence in a Complex and Chaotic World' and 'Building Manufacturing Competitiveness -
the TOC Way'; and is a co-creator of the book, 'Business Model Generation'. Earlier in his career, he held leadership
positions with the Swiss conglomerate ABB in manufacturing, service and R&D businesses. An engineer by
qualification, Shridhar holds a PhD from Indian Institute of Technology - Delhi.